EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis : Ankara 2008. Part II: Final classification criteria
OBJECTIVES: To validate the previously proposed classification criteria for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA).
METHODS: Step 1: retrospective/prospective web-data collection for children with HSP, c-PAN, c-WG and c-TA with age at diagnosis <or=18 years. Step 2: blinded classification by consensus panel of a representative sample of 280 cases. Step 3: statistical (sensitivity, specificity, area under the curve and kappa-agreement) and nominal group technique consensus evaluations.
RESULTS: 827 patients with HSP, 150 with c-PAN, 60 with c-WG, 87 with c-TA and 52 with c-other were compared with each other. A patient was classified as HSP in the presence of purpura or petechiae (mandatory) with lower limb predominance plus one of four criteria: (1) abdominal pain; (2) histopathology (IgA); (3) arthritis or arthralgia; (4) renal involvement. Classification of c-PAN required a systemic inflammatory disease with evidence of necrotising vasculitis OR angiographic abnormalities of medium-/small-sized arteries (mandatory criterion) plus one of five criteria: (1) skin involvement; (2) myalgia/muscle tenderness; (3) hypertension; (4) peripheral neuropathy; (5) renal involvement. Classification of c-WG required three of six criteria: (1) histopathological evidence of granulomatous inflammation; (2) upper airway involvement; (3) laryngo-tracheo-bronchial involvement; (4) pulmonary involvement (x-ray/CT); (5) antineutrophilic cytoplasmic antibody positivity; (6) renal involvement. Classification of c-TA required typical angiographic abnormalities of the aorta or its main branches and pulmonary arteries (mandatory criterion) plus one of five criteria: (1) pulse deficit or claudication; (2) blood pressure discrepancy in any limb; (3) bruits; (4) hypertension; (5) elevated acute phase reactant.
CONCLUSION: European League Against Rheumatism/Paediatric Rheumatology International Trials Organisation/Paediatric Rheumatology European Society propose validated classification criteria for HSP, c-PAN, c-WG and c-TA with high sensitivity/specificity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 69(2010), 5 vom: 21. Mai, Seite 798-806 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Consensus Development Conference |
|---|
| Anmerkungen: |
Date Completed 15.06.2010 Date Revised 19.04.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/ard.2009.116657 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM19755279X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM19755279X | ||
| 003 | DE-627 | ||
| 005 | 20231223210819.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard.2009.116657 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0659.xml |
| 035 | |a (DE-627)NLM19755279X | ||
| 035 | |a (NLM)20413568 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ozen, Seza |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis |b Ankara 2008. Part II: Final classification criteria |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.06.2010 | ||
| 500 | |a Date Revised 19.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVES: To validate the previously proposed classification criteria for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) | ||
| 520 | |a METHODS: Step 1: retrospective/prospective web-data collection for children with HSP, c-PAN, c-WG and c-TA with age at diagnosis <or=18 years. Step 2: blinded classification by consensus panel of a representative sample of 280 cases. Step 3: statistical (sensitivity, specificity, area under the curve and kappa-agreement) and nominal group technique consensus evaluations | ||
| 520 | |a RESULTS: 827 patients with HSP, 150 with c-PAN, 60 with c-WG, 87 with c-TA and 52 with c-other were compared with each other. A patient was classified as HSP in the presence of purpura or petechiae (mandatory) with lower limb predominance plus one of four criteria: (1) abdominal pain; (2) histopathology (IgA); (3) arthritis or arthralgia; (4) renal involvement. Classification of c-PAN required a systemic inflammatory disease with evidence of necrotising vasculitis OR angiographic abnormalities of medium-/small-sized arteries (mandatory criterion) plus one of five criteria: (1) skin involvement; (2) myalgia/muscle tenderness; (3) hypertension; (4) peripheral neuropathy; (5) renal involvement. Classification of c-WG required three of six criteria: (1) histopathological evidence of granulomatous inflammation; (2) upper airway involvement; (3) laryngo-tracheo-bronchial involvement; (4) pulmonary involvement (x-ray/CT); (5) antineutrophilic cytoplasmic antibody positivity; (6) renal involvement. Classification of c-TA required typical angiographic abnormalities of the aorta or its main branches and pulmonary arteries (mandatory criterion) plus one of five criteria: (1) pulse deficit or claudication; (2) blood pressure discrepancy in any limb; (3) bruits; (4) hypertension; (5) elevated acute phase reactant | ||
| 520 | |a CONCLUSION: European League Against Rheumatism/Paediatric Rheumatology International Trials Organisation/Paediatric Rheumatology European Society propose validated classification criteria for HSP, c-PAN, c-WG and c-TA with high sensitivity/specificity | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Validation Study | |
| 700 | 1 | |a Pistorio, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Iusan, Silvia M |e verfasserin |4 aut | |
| 700 | 1 | |a Bakkaloglu, Aysin |e verfasserin |4 aut | |
| 700 | 1 | |a Herlin, Troels |e verfasserin |4 aut | |
| 700 | 1 | |a Brik, Riva |e verfasserin |4 aut | |
| 700 | 1 | |a Buoncompagni, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Lazar, Calin |e verfasserin |4 aut | |
| 700 | 1 | |a Bilge, Ilmay |e verfasserin |4 aut | |
| 700 | 1 | |a Uziel, Yosef |e verfasserin |4 aut | |
| 700 | 1 | |a Rigante, Donato |e verfasserin |4 aut | |
| 700 | 1 | |a Cantarini, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Hilario, Maria Odete |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Clovis A |e verfasserin |4 aut | |
| 700 | 1 | |a Alegria, Mauricio |e verfasserin |4 aut | |
| 700 | 1 | |a Norambuena, Ximena |e verfasserin |4 aut | |
| 700 | 1 | |a Belot, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Berkun, Yackov |e verfasserin |4 aut | |
| 700 | 1 | |a Estrella, Amparo Ibanez |e verfasserin |4 aut | |
| 700 | 1 | |a Olivieri, Alma Nunzia |e verfasserin |4 aut | |
| 700 | 1 | |a Alpigiani, Maria Giannina |e verfasserin |4 aut | |
| 700 | 1 | |a Rumba, Ingrida |e verfasserin |4 aut | |
| 700 | 1 | |a Sztajnbok, Flavio |e verfasserin |4 aut | |
| 700 | 1 | |a Tambic-Bukovac, Lana |e verfasserin |4 aut | |
| 700 | 1 | |a Breda, Luciana |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Mayouf, Sulaiman |e verfasserin |4 aut | |
| 700 | 1 | |a Mihaylova, Dimitrina |e verfasserin |4 aut | |
| 700 | 1 | |a Chasnyk, Vyacheslav |e verfasserin |4 aut | |
| 700 | 1 | |a Sengler, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Klein-Gitelman, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Djeddi, Djamal |e verfasserin |4 aut | |
| 700 | 1 | |a Nuno, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Pruunsild, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Brunner, Jurgen |e verfasserin |4 aut | |
| 700 | 1 | |a Kondi, Anuela |e verfasserin |4 aut | |
| 700 | 1 | |a Pagava, Karaman |e verfasserin |4 aut | |
| 700 | 1 | |a Pederzoli, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Martini, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ruperto, Nicolino |e verfasserin |4 aut | |
| 700 | 0 | |a Paediatric Rheumatology International Trials Organisation (PRINTO) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 69(2010), 5 vom: 21. Mai, Seite 798-806 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2010 |g number:5 |g day:21 |g month:05 |g pages:798-806 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard.2009.116657 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2010 |e 5 |b 21 |c 05 |h 798-806 | ||